Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017 (2017), Article ID 2707082, 11 pages
https://doi.org/10.1155/2017/2707082
Review Article

Potential Therapeutic Mechanisms and Tracking of Transplanted Stem Cells: Implications for Stroke Treatment

1Department of Pharmacology, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China
2Key Laboratory of Developmental Genes and Human Disease, Institute of Life Sciences, Southeast University, Nanjing, Jiangsu 210096, China

Correspondence should be addressed to Honghong Yao; nc.ude.ues@hhoay

Received 6 May 2017; Revised 8 July 2017; Accepted 30 July 2017; Published 20 August 2017

Academic Editor: Yao Li

Copyright © 2017 Yanhong Zhang and Honghong Yao. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Hu, T. M. De Silva, J. Chen, and F. M. Faraci, “Cerebral vascular disease and neurovascular injury in ischemic stroke,” Circulation Research, vol. 120, no. 3, pp. 449–471, 2017. View at Publisher · View at Google Scholar
  2. S. A. Acosta, N. Tajiri, J. Hoover, Y. Kaneko, and C. V. Borlongan, “Intravenous bone marrow stem cell grafts preferentially migrate to spleen and abrogate chronic inflammation in stroke,” Stroke, vol. 46, no. 9, pp. 2616–2627, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Baltan, R. S. Morrison, and S. P. Murphy, “Novel protective effects of histone deacetylase inhibition on stroke and white matter ischemic injury,” Neurotherapeutics, vol. 10, no. 4, pp. 798–807, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Denorme and S. F. De Meyer, “The VWF-GPIb axis in ischaemic stroke: lessons from animal models,” Thrombosis and Haemostasis, vol. 116, no. 4, pp. 597–604, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Vemuganti, “All’s well that transcribes well: non-coding RNAs and post-stroke brain damage,” Neurochemistry International, vol. 63, no. 5, pp. 438–449, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. E. J. Benjamin, M. J. Blaha, S. E. Chiuve et al., “Heart disease and stroke statistics-2017 update: a report from the American Heart Association,” Circulation, vol. 135, no. 10, pp. e146–e603, 2017. View at Publisher · View at Google Scholar
  7. Writing Group Members, D. Mozaffarian, E. J. Benjamin et al., “Executive summary: heart disease and stroke statistics—2016 update: a report from the American Heart Association,” Circulation, vol. 133, no. 4, pp. 447–454, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. G. J. Hankey, “Stroke,” Lancet, vol. 389, no. 10069, pp. 641–654, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. N. R. Sims and H. Muyderman, “Mitochondria, oxidative metabolism and cell death in stroke,” Biochimica et Biophysica Acta, vol. 1802, no. 1, pp. 80–91, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Puyal, V. Ginet, and P. G. Clarke, “Multiple interacting cell death mechanisms in the mediation of excitotoxicity and ischemic brain damage: a challenge for neuroprotection,” Progress in Neurobiology, vol. 105, pp. 24–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Szigeti, I. Horvath, D. S. Veres et al., “A novel SPECT-based approach reveals early mechanisms of central and peripheral inflammation after cerebral ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 35, no. 12, pp. 1921–1929, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Chamorro, U. Dirnagl, X. Urra, and A. M. Planas, “Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation,” Lancet Neurology, vol. 15, no. 8, pp. 869–881, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Wei, Z. Z. Wei, M. Q. Jiang, O. Mohamad, and S. P. Yu, “Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke,” Progress in Neurobiology, 2017. View at Publisher · View at Google Scholar
  14. A. Durukan and T. Tatlisumak, “Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia,” Pharmacology, Biochemistry, and Behavior, vol. 87, no. 1, pp. 179–197, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Morihara, S. Kono, K. Sato et al., “Thrombolysis with low-dose tissue plasminogen activator 3-4.5 h after acute ischemic stroke in five hospital groups in Japan,” Translational Stroke Research, vol. 7, no. 2, pp. 111–119, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Liu, Y. Wang, Y. Xiao, Z. Hua, J. Cheng, and J. Jia, “Hydrogen sulfide attenuates tissue plasminogen activator-induced cerebral hemorrhage following experimental stroke,” Translational Stroke Research, vol. 7, no. 3, pp. 209–219, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. M. G. Hennerici, “Is there a new era for stroke therapy?” Cerebrovascular Diseases, vol. 40, no. 1-2, pp. I–II, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Reinhard, C. A. Taschner, N. Horsch et al., “Endovascular treatment versus sonothrombolysis for acute ischemic stroke,” Cerebrovascular Diseases, vol. 40, no. 5-6, pp. 205–214, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. B. C. Campbell, P. J. Mitchell, T. J. Kleinig et al., “Endovascular therapy for ischemic stroke with perfusion-imaging selection,” The New England Journal of Medicine, vol. 372, no. 11, pp. 1009–1018, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Goyal, A. M. Demchuk, B. K. Menon et al., “Randomized assessment of rapid endovascular treatment of ischemic stroke,” The New England Journal of Medicine, vol. 372, no. 11, pp. 1019–1030, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. O. A. Berkhemer, P. S. Fransen, D. Beumer et al., “A randomized trial of intraarterial treatment for acute ischemic stroke,” The New England Journal of Medicine, vol. 372, no. 1, pp. 11–20, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. Q. Alhadidi, M. S. Bin Sayeed, and Z. A. Shah, “Cofilin as a promising therapeutic target for ischemic and hemorrhagic stroke,” Translational Stroke Research, vol. 7, no. 1, pp. 33–41, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Wu and J. C. Izpisua Belmonte, “Stem cells: a renaissance in human biology research,” Cell, vol. 165, no. 7, pp. 1572–1585, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Zhang, F. Sun, J. Wang et al., “Combining injectable plasma scaffold with mesenchymal stem/stromal cells for repairing infarct cavity after ischemic stroke,” Aging and Disease, vol. 8, no. 2, pp. 203–214, 2017. View at Publisher · View at Google Scholar
  25. L. Huang, Y. Liu, J. Lu, B. Cerqueira, V. Misra, and T. Q. Duong, “Intraarterial transplantation of human umbilical cord blood mononuclear cells in hyperacute stroke improves vascular function,” Stem Cell Research & Therapy, vol. 8, no. 1, p. 74, 2017. View at Publisher · View at Google Scholar
  26. J. D. Bernstock, L. Peruzzotti-Jametti, D. Ye et al., “Neural stem cell transplantation in ischemic stroke: a role for preconditioning and cellular engineering,” Journal of Cerebral Blood Flow and Metabolism, vol. 37, no. 7, pp. 2314–2319, 2017. View at Publisher · View at Google Scholar
  27. K. Zhao, R. Li, C. Gu et al., “Intravenous administration of adipose-derived stem cell protein extracts improves neurological deficits in a rat model of stroke,” Stem Cells International, vol. 2017, Article ID 2153629, 11 pages, 2017. View at Publisher · View at Google Scholar
  28. M. Uemura, Y. Kasahara, K. Nagatsuka, and A. Taguchi, “Cell-based therapy to promote angiogenesis in the brain following ischemic damage,” Current Vascular Pharmacology, vol. 10, no. 3, pp. 285–288, 2012. View at Google Scholar
  29. H. J. Lee, I. J. Lim, M. C. Lee, and S. U. Kim, “Human neural stem cells genetically modified to overexpress brain-derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model,” Journal of Neuroscience Research, vol. 88, no. 15, pp. 3282–3294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Redondo-Castro, C. Cunningham, J. Miller et al., “Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro,” Stem Cell Research & Therapy, vol. 8, no. 1, p. 79, 2017. View at Publisher · View at Google Scholar
  31. C. C. Chen, L. Liu, F. Ma et al., “Elucidation of exosome migration across the blood-brain barrier model in vitro,” Cellular and Molecular Bioengineering, vol. 9, no. 4, pp. 509–529, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Sun, X. Ma, J. Wang et al., “Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal,” Oncotarget, vol. 8, no. 22, pp. 36137–36148, 2017. View at Publisher · View at Google Scholar
  33. H. Haga, I. K. Yan, D. Borelli et al., “Extracellular vesicles from bone marrow derived mesenchymal stem cells protect against murine hepatic ischemia-reperfusion injury,” Liver Transplantation, vol. 23, no. 6, pp. 791–803, 2017. View at Publisher · View at Google Scholar
  34. M. Chopp and Z. G. Zhang, “Emerging potential of exosomes and noncoding microRNAs for the treatment of neurological injury/diseases,” Expert Opinion on Emerging Drugs, vol. 20, no. 4, pp. 523–526, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. X. Wang and J. M. Idee, “A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging,” Quantitative Imaging in Medicine and Surgery, vol. 7, no. 1, pp. 88–122, 2017. View at Publisher · View at Google Scholar
  36. P. Keselman, E. Y. Yu, X. Y. Zhou et al., “Tracking short-term biodistribution and long-term clearance of SPIO tracers in magnetic particle imaging,” Physics in Medicine and Biology, vol. 62, no. 9, pp. 3440–3453, 2017. View at Publisher · View at Google Scholar
  37. Q. Liang, Y. X. Wang, J. S. Ding et al., “Intra-arterial delivery of superparamagnetic iron-oxide nanoshell and polyvinyl alcohol based chemoembolization system for the treatment of liver tumor,” Discovery Medicine, vol. 23, no. 124, pp. 27–39, 2017. View at Google Scholar
  38. A. S. Arbab, C. Thiffault, B. Navia et al., “Tracking of In-111-labeled human umbilical tissue-derived cells (hUTC) in a rat model of cerebral ischemia using SPECT imaging,” BMC Medical Imaging, vol. 12, p. 33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Tang, C. Zhang, J. Wang et al., “MRI/SPECT/fluorescent tri-modal probe for evaluating the homing and therapeutic efficacy of transplanted mesenchymal stem cells in a rat ischemic stroke model,” Advanced Functional Materials, vol. 25, no. 7, pp. 1024–1034, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Basset, J. P. Bellocq, C. Wolf et al., “A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas,” Nature, vol. 348, no. 6303, pp. 699–704, 1990. View at Publisher · View at Google Scholar
  41. M. M. Daadi, Z. Li, A. Arac et al., “Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain,” Molecular Therapy, vol. 17, no. 7, pp. 1282–1291, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. K. Choi, E. Urnukhsaikhan, H. H. Yoon, Y. K. Seo, and J. K. Park, “Effect of human mesenchymal stem cell transplantation on cerebral ischemic volume-controlled photothrombotic mouse model,” Biotechnology Journal, vol. 11, no. 11, pp. 1397–1404, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. A. U. Hicks, R. S. Lappalainen, S. Narkilahti et al., “Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery,” The European Journal of Neuroscience, vol. 29, no. 3, pp. 562–574, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. V. Darsalia, T. Kallur, and Z. Kokaia, “Survival, migration and neuronal differentiation of human fetal striatal and cortical neural stem cells grafted in stroke-damaged rat striatum,” The European Journal of Neuroscience, vol. 26, no. 3, pp. 605–614, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. M. M. Daadi, A. L. Maag, and G. K. Steinberg, “Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model,” PLoS One, vol. 3, no. 2, article e1644, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Cheng, J. Zhang, L. Deng et al., “Intravenously delivered neural stem cells migrate into ischemic brain, differentiate and improve functional recovery after transient ischemic stroke in adult rats,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 3, pp. 2928–2936, 2015. View at Google Scholar
  47. R. H. Andres, N. Horie, W. Slikker et al., “Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain,” Brain, vol. 134, Part 6, pp. 1777–1789, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. N. Horie, M. P. Pereira, K. Niizuma et al., “Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair,” Stem Cells, vol. 29, no. 2, pp. 274–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Lois and A. Alvarez-Buylla, “Long-distance neuronal migration in the adult mammalian brain,” Science, vol. 264, no. 5162, pp. 1145–1148, 1994. View at Google Scholar
  50. S. H. Koh and H. H. Park, “Neurogenesis in stroke recovery,” Translational Stroke Research, vol. 8, no. 1, pp. 3–13, 2017. View at Publisher · View at Google Scholar · View at Scopus
  51. A. O. Ihunwo, L. H. Tembo, and C. Dzamalala, “The dynamics of adult neurogenesis in human hippocampus,” Neural Regeneration Research, vol. 11, no. 12, pp. 1869–1883, 2016. View at Publisher · View at Google Scholar
  52. K. L. Spalding, O. Bergmann, K. Alkass et al., “Dynamics of hippocampal neurogenesis in adult humans,” Cell, vol. 153, no. 6, pp. 1219–1227, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. R. L. Zhang, M. Chopp, C. Roberts et al., “Stroke increases neural stem cells and angiogenesis in the neurogenic niche of the adult mouse,” PLoS One, vol. 9, no. 12, article e113972, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Ling, S. Zhang, Z. Ji et al., “Therapeutic effects of lipo-prostaglandin E1 on angiogenesis and neurogenesis after ischemic stroke in rats,” The International Journal of Neuroscience, vol. 126, no. 5, pp. 469–477, 2016. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Nakata, T. Nakagomi, M. Maeda, A. Nakano-Doi, Y. Momota, and T. Matsuyama, “Induction of perivascular neural stem cells and possible contribution to neurogenesis following transient brain ischemia/reperfusion injury,” Translational Stroke Research, vol. 8, no. 2, pp. 131–143, 2017. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Ryu, S. H. Lee, S. U. Kim, and B. W. Yoon, “Human neural stem cells promote proliferation of endogenous neural stem cells and enhance angiogenesis in ischemic rat brain,” Neural Regeneration Research, vol. 11, no. 2, pp. 298–304, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Marti-Fabregas, M. Romaguera-Ros, U. Gomez-Pinedo et al., “Proliferation in the human ipsilateral subventricular zone after ischemic stroke,” Neurology, vol. 74, no. 5, pp. 357–365, 2010. View at Publisher · View at Google Scholar
  58. C. A. Gregoire, B. L. Goldenstein, E. M. Floriddia, F. Barnabé-Heider, and K. J. Fernandes, “Endogenous neural stem cell responses to stroke and spinal cord injury,” Glia, vol. 63, no. 8, pp. 1469–1482, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Hayashi, N. Noshita, T. Sugawara, and P. H. Chan, “Temporal profile of angiogenesis and expression of related genes in the brain after ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 23, no. 2, pp. 166–180, 2003. View at Publisher · View at Google Scholar
  60. M. Faiz, N. Sachewsky, S. Gascon, K. W. Bang, C. M. Morshead, and A. Nagy, “Adult neural stem cells from the subventricular zone give rise to reactive astrocytes in the cortex after stroke,” Cell Stem Cell, vol. 17, no. 5, pp. 624–634, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. I. A. Qureshi and M. F. Mehler, “Chromatin-modifying agents for epigenetic reprogramming and endogenous neural stem cell-mediated repair in stroke,” Translational Stroke Research, vol. 2, no. 1, pp. 7–16, 2011. View at Google Scholar
  62. M. Song, S. P. Yu, O. Mohamad et al., “Optogenetic stimulation of glutamatergic neuronal activity in the striatum enhances neurogenesis in the subventricular zone of normal and stroke mice,” Neurobiology of Disease, vol. 98, pp. 9–24, 2017. View at Publisher · View at Google Scholar
  63. G. Camussi, M. C. Deregibus, and V. Cantaluppi, “Role of stem-cell-derived microvesicles in the paracrine action of stem cells,” Biochemical Society Transactions, vol. 41, no. 1, pp. 283–287, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. T. R. Doeppner, J. Herz, A. Gorgens et al., “Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression,” Stem Cells Translational Medicine, vol. 4, no. 10, pp. 1131–1143, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. B. Gyorgy, M. E. Hung, X. O. Breakefield, and J. N. Leonard, “Therapeutic applications of extracellular vesicles: clinical promise and open questions,” Annual Review of Pharmacology and Toxicology, vol. 55, pp. 439–464, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. B. Zheng, W. N. Yin, T. Suzuki et al., “Exosome-mediated miR-155 transfer from smooth muscle cells to endothelial cells induces endothelial injury and promotes atherosclerosis,” Molecular Therapy, vol. 25, no. 6, pp. 1279–1294, 2017. View at Publisher · View at Google Scholar
  67. L. Qu, J. Ding, C. Chen et al., “Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA,” Cancer Cell, vol. 29, no. 5, pp. 653–668, 2016. View at Publisher · View at Google Scholar · View at Scopus
  68. G. K. Panigrahi and G. Deep, “Exosomes-based biomarker discovery for diagnosis and prognosis of prostate cancer,” Frontiers in Bioscience (Landmark Edition), vol. 22, pp. 1682–1696, 2017. View at Google Scholar
  69. R. Xu, D. W. Greening, H. J. Zhu, N. Takahashi, and R. J. Simpson, “Extracellular vesicle isolation and characterization: toward clinical application,” The Journal of Clinical Investigation, vol. 126, no. 4, pp. 1152–1162, 2016. View at Publisher · View at Google Scholar · View at Scopus
  70. V. Hyenne, M. Labouesse, and J. G. Goetz, “The small GTPase Ral orchestrates MVB biogenesis and exosome secretion,” Small GTPases, pp. 1–7, 2016. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Kowal, M. Tkach, and C. Thery, “Biogenesis and secretion of exosomes,” Current Opinion in Cell Biology, vol. 29, pp. 116–125, 2014. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Xin, Y. Li, Y. Cui, J. J. Yang, Z. G. Zhang, and M. Chopp, “Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats,” Journal of Cerebral Blood Flow and Metabolism, vol. 33, no. 11, pp. 1711–1715, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. H. Xin, F. Wang, Y. Li et al., “Secondary release of exosomes from astrocytes contributes to the increase in neural plasticity and improvement of functional recovery after stroke in rats treated with exosomes harvested from microRNA 133b-overexpressing multipotent mesenchymal stromal cells,” Cell Transplantation, vol. 26, no. 2, pp. 243–257, 2017. View at Publisher · View at Google Scholar
  74. K. H. Chen, C. H. Chen, C. G. Wallace et al., “Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stroke,” Oncotarget, vol. 7, no. 46, pp. 74537–74556, 2016. View at Publisher · View at Google Scholar · View at Scopus
  75. W. T. Tse, J. D. Pendleton, W. M. Beyer, M. C. Egalka, and E. C. Guinan, “Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation,” Transplantation, vol. 75, no. 3, pp. 389–397, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. D. J. Chang, N. Lee, C. Choi et al., “Therapeutic effect of BDNF-overexpressing human neural stem cells (HB1.F3.BDNF) in a rodent model of middle cerebral artery occlusion,” Cell Transplantation, vol. 22, no. 8, pp. 1441–1452, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Rosenblum, T. N. Smith, N. Wang et al., “BDNF pretreatment of human embryonic-derived neural stem cells improves cell survival and functional recovery after transplantation in hypoxic-ischemic stroke,” Cell Transplantation, vol. 24, no. 12, pp. 2449–2461, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. E. Atangana, U. C. Schneider, K. Blecharz et al., “Intravascular inflammation triggers intracerebral activated microglia and contributes to secondary brain injury after experimental subarachnoid hemorrhage (eSAH),” Translational Stroke Research, vol. 8, no. 2, pp. 144–156, 2017. View at Publisher · View at Google Scholar · View at Scopus
  79. N. Sun, R. F. Keep, Y. Hua, and G. Xi, “Critical role of the sphingolipid pathway in stroke: a review of current utility and potential therapeutic targets,” Translational Stroke Research, vol. 7, no. 5, pp. 420–438, 2016. View at Publisher · View at Google Scholar · View at Scopus
  80. C. Justicia, J. Panes, S. Sole et al., “Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats,” Journal of Cerebral Blood Flow and Metabolism, vol. 23, no. 12, pp. 1430–1440, 2003. View at Publisher · View at Google Scholar
  81. E. Kolaczkowska and P. Kubes, “Neutrophil recruitment and function in health and inflammation,” Nature Reviews Immunology, vol. 13, no. 3, pp. 159–175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Cervera, A. M. Planas, C. Justicia et al., “Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke,” PLoS One, vol. 5, no. 2, article e8433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. B. Lv, F. Li, J. Han et al., “Hif-1alpha overexpression improves transplanted bone mesenchymal stem cells survival in rat MCAO stroke model,” Frontiers in Molecular Neuroscience, vol. 10, p. 80, 2017. View at Publisher · View at Google Scholar
  84. A. Aziz, E. Soucie, S. Sarrazin, and M. H. Sieweke, “MafB/c-Maf deficiency enables self-renewal of differentiated functional macrophages,” Science, vol. 326, no. 5954, pp. 867–871, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. E. L. Soucie, Z. Weng, L. Geirsdottir et al., “Lineage-specific enhancers activate self-renewal genes in macrophages and embryonic stem cells,” Science, vol. 351, no. 6274, article aad5510, 2016. View at Publisher · View at Google Scholar · View at Scopus
  86. T. Shichita, M. Ito, R. Morita et al., “MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1,” Nature Medicine, vol. 23, no. 6, pp. 723–732, 2017. View at Publisher · View at Google Scholar
  87. R. S. Pandya, L. Mao, H. Zhou et al., “Central nervous system agents for ischemic stroke: neuroprotection mechanisms,” Central Nervous System Agents in Medicinal Chemistry, vol. 11, no. 2, pp. 81–97, 2011. View at Google Scholar
  88. N. A. Belle, G. D. Dalmolin, G. Fonini, M. A. Rubin, and J. B. Rocha, “Polyamines reduces lipid peroxidation induced by different pro-oxidant agents,” Brain Research, vol. 1008, no. 2, pp. 245–251, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. J. Li, K. M. Doyle, and T. Tatlisumak, “Polyamines in the brain: distribution, biological interactions, and their potential therapeutic role in brain ischaemia,” Current Medicinal Chemistry, vol. 14, no. 17, pp. 1807–1813, 2007. View at Google Scholar
  90. M. D. Shirhan, S. M. Moochhala, P. Y. Ng et al., “Spermine reduces infarction and neurological deficit following a rat model of middle cerebral artery occlusion: a magnetic resonance imaging study,” Neuroscience, vol. 124, no. 2, pp. 299–304, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. T. H. Shin, G. Phukan, J. S. Shim et al., “Restoration of polyamine metabolic patterns in in vivo and in vitro model of ischemic stroke following human mesenchymal stem cell treatment,” Stem Cells International, vol. 2016, Article ID 4612531, 11 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  92. N. Egawa, J. Lok, K. Washida, and K. Arai, “Mechanisms of axonal damage and repair after central nervous system injury,” Translational Stroke Research, vol. 8, no. 1, pp. 14–21, 2017. View at Publisher · View at Google Scholar · View at Scopus
  93. C. Xing, K. Hayakawa, and E. H. Lo, “Mechanisms, imaging, and therapy in stroke recovery,” Translational Stroke Research, vol. 8, no. 1, pp. 1-2, 2017. View at Publisher · View at Google Scholar · View at Scopus
  94. H. Xin, Y. Li, Z. Liu et al., “MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles,” Stem Cells, vol. 31, no. 12, pp. 2737–2746, 2013. View at Publisher · View at Google Scholar · View at Scopus
  95. H. Xin, Y. Li, B. Buller et al., “Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth,” Stem Cells, vol. 30, no. 7, pp. 1556–1564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. G. K. Steinberg, D. Kondziolka, L. R. Wechsler et al., “Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1/2a study,” Stroke, vol. 47, no. 7, pp. 1817–1824, 2016. View at Publisher · View at Google Scholar · View at Scopus
  97. Q. Vu, K. Xie, M. Eckert, W. Zhao, and S. C. Cramer, “Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke,” Neurology, vol. 82, no. 14, pp. 1277–1286, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. D. Kondziolka, G. K. Steinberg, L. Wechsler et al., “Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial,” Journal of Neurosurgery, vol. 103, no. 1, pp. 38–45, 2005. View at Publisher · View at Google Scholar
  99. K. Prasad, A. Sharma, A. Garg et al., “Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial,” Stroke, vol. 45, no. 12, pp. 3618–3624, 2014. View at Publisher · View at Google Scholar · View at Scopus
  100. A. A. Ghali, M. K. Yousef, O. A. Ragab, and E. A. ElZamarany, “Intra-arterial infusion of autologous bone marrow mononuclear stem cells in subacute ischemic stroke patients,” Frontiers in Neurology, vol. 7, p. 228, 2016. View at Publisher · View at Google Scholar · View at Scopus
  101. M. G. Liska, M. G. Crowley, and C. V. Borlongan, “Regulated and unregulated clinical trials of stem cell therapies for stroke,” Translational Stroke Research, vol. 8, no. 2, pp. 93–103, 2017. View at Publisher · View at Google Scholar
  102. V. F. Segers and R. T. Lee, “Stem-cell therapy for cardiac disease,” Nature, vol. 451, no. 7181, pp. 937–942, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. B. Rodriguez-Frutos, L. Otero-Ortega, M. Gutierrez-Fernandez, B. Fuentes, J. Ramos-Cejudo, and E. Díez-Tejedor, “Stem cell therapy and administration routes after stroke,” Translational Stroke Research, vol. 7, no. 5, pp. 378–387, 2016. View at Publisher · View at Google Scholar · View at Scopus
  104. J. Biernaskie, D. Corbett, J. Peeling, J. Wells, and H. Lei, “A serial MR study of cerebral blood flow changes and lesion development following endothelin-1-induced ischemia in rats,” Magnetic Resonance in Medicine, vol. 46, no. 4, pp. 827–830, 2001. View at Google Scholar
  105. Z. Z. Wei, X. Gu, A. Ferdinand et al., “Intranasal delivery of bone marrow mesenchymal stem cells improved neurovascular regeneration and rescued neuropsychiatric deficits after neonatal stroke in rats,” Cell Transplantation, vol. 24, no. 3, pp. 391–402, 2015. View at Publisher · View at Google Scholar · View at Scopus
  106. N. Wei, S. P. Yu, X. Gu et al., “Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice,” Cell Transplantation, vol. 22, no. 6, pp. 977–991, 2013. View at Publisher · View at Google Scholar · View at Scopus
  107. M. Srinivas, P. Boehm-Sturm, C. G. Figdor, I. J. de Vries, and M. Hoehn, “Labeling cells for in vivo tracking using (19)F MRI,” Biomaterials, vol. 33, no. 34, pp. 8830–8840, 2012. View at Publisher · View at Google Scholar · View at Scopus
  108. T. J. Wu, Y. K. Tzeng, W. W. Chang et al., “Tracking the engraftment and regenerative capabilities of transplanted lung stem cells using fluorescent nanodiamonds,” Nature Nanotechnology, vol. 8, no. 9, pp. 682–689, 2013. View at Publisher · View at Google Scholar · View at Scopus
  109. X. Liang, L. Fang, X. Li, X. Zhang, and F. Wang, “Activatable near infrared dye conjugated hyaluronic acid based nanoparticles as a targeted theranostic agent for enhanced fluorescence/CT/photoacoustic imaging guided photothermal therapy,” Biomaterials, vol. 132, pp. 72–84, 2017. View at Publisher · View at Google Scholar
  110. A. B. Alenazy, R. G. Wells, and T. D. Ruddy, “New solid state cadmium-zinc-telluride technology for cardiac single photon emission computed tomographic myocardial perfusion imaging,” Expert Review of Medical Devices, vol. 14, no. 3, pp. 213–222, 2017. View at Publisher · View at Google Scholar
  111. A. T. Chan and M. R. Abraham, “SPECT and PET to optimize cardiac stem cell therapy,” Journal of Nuclear Cardiology, vol. 19, no. 1, pp. 118–125, 2012. View at Publisher · View at Google Scholar · View at Scopus
  112. O. Detante, S. Valable, F. de Fraipont et al., “Magnetic resonance imaging and fluorescence labeling of clinical-grade mesenchymal stem cells without impacting their phenotype: study in a rat model of stroke,” Stem Cells Translational Medicine, vol. 1, no. 4, pp. 333–341, 2012. View at Publisher · View at Google Scholar · View at Scopus
  113. P. Hua, Y. Y. Wang, L. B. Liu et al., “In vivo magnetic resonance imaging tracking of transplanted superparamagnetic iron oxide-labeled bone marrow mesenchymal stem cells in rats with myocardial infarction,” Molecular Medicine Reports, vol. 11, no. 1, pp. 113–120, 2015. View at Publisher · View at Google Scholar · View at Scopus
  114. L. Li, Q. Jiang, G. Ding et al., “Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study,” Journal of Cerebral Blood Flow and Metabolism, vol. 30, no. 3, pp. 653–662, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. J. H. Cho, K. S. Hong, J. Cho et al., “Detection of iron-labeled single cells by MR imaging based on intermolecular double quantum coherences at 14 T,” Journal of Magnetic Resonance, vol. 217, pp. 86–91, 2012. View at Publisher · View at Google Scholar · View at Scopus
  116. T. J. England, P. M. Bath, M. Abaei, D. Auer, and D. R. Jones, “Hematopoietic stem cell (CD34+) uptake of superparamagnetic iron oxide is enhanced by but not dependent on a transfection agent,” Cytotherapy, vol. 15, no. 3, pp. 384–390, 2013. View at Publisher · View at Google Scholar · View at Scopus
  117. L. Zhang, Y. Wang, Y. Tang et al., “High MRI performance fluorescent mesoporous silica-coated magnetic nanoparticles for tracking neural progenitor cells in an ischemic mouse model,” Nanoscale, vol. 5, no. 10, pp. 4506–4516, 2013. View at Publisher · View at Google Scholar · View at Scopus
  118. Y. Wang, F. Xu, C. Zhang et al., “High MR sensitive fluorescent magnetite nanocluster for stem cell tracking in ischemic mouse brain,” Nanomedicine, vol. 7, no. 6, pp. 1009–1019, 2011. View at Publisher · View at Google Scholar · View at Scopus
  119. S. S. Lu, S. Liu, Q. Q. Zu et al., “In vivo MR imaging of intraarterially delivered magnetically labeled mesenchymal stem cells in a canine stroke model,” PLoS One, vol. 8, no. 2, article e54963, 2013. View at Publisher · View at Google Scholar · View at Scopus
  120. M. A. Kolecka, S. Arnhold, M. Schmidt et al., “Behaviour of adipose-derived canine mesenchymal stem cells after superparamagnetic iron oxide nanoparticles labelling for magnetic resonance imaging,” BMC Veterinary Research, vol. 13, no. 1, p. 62, 2017. View at Publisher · View at Google Scholar
  121. H. Ittrich, K. Peldschus, N. Raabe, M. Kaul, and G. Adam, “Superparamagnetic iron oxide nanoparticles in biomedicine: applications and developments in diagnostics and therapy,” Rofo, vol. 185, no. 12, pp. 1149–1166, 2013. View at Publisher · View at Google Scholar · View at Scopus
  122. E. U. Saritas, P. W. Goodwill, L. R. Croft et al., “Magnetic particle imaging (MPI) for NMR and MRI researchers,” Journal of Magnetic Resonance, vol. 229, pp. 116–126, 2013. View at Publisher · View at Google Scholar · View at Scopus
  123. J. Weizenecker, B. Gleich, J. Rahmer, H. Dahnke, and J. Borgert, “Three-dimensional real-time in vivo magnetic particle imaging,” Physics in Medicine and Biology, vol. 54, no. 5, pp. L1–L10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. P. W. Goodwill and S. M. Conolly, “The X-space formulation of the magnetic particle imaging process: 1-D signal, resolution, bandwidth, SNR, SAR, and magnetostimulation,” IEEE Transactions on Medical Imaging, vol. 29, no. 11, pp. 1851–1859, 2010. View at Publisher · View at Google Scholar · View at Scopus
  125. X. Y. Zhou, K. E. Jeffris, E. Y. Yu et al., “First in vivo magnetic particle imaging of lung perfusion in rats,” Physics in Medicine and Biology, vol. 62, no. 9, pp. 3510–3522, 2017. View at Publisher · View at Google Scholar
  126. B. Zheng, E. Yu, R. Orendorff et al., “Seeing SPIOs directly in vivo with magnetic particle imaging,” Molecular Imaging and Biology, vol. 19, no. 3, pp. 385–390, 2017. View at Publisher · View at Google Scholar
  127. A. P. Khandhar, P. Keselman, S. J. Kemp et al., “Evaluation of PEG-coated iron oxide nanoparticles as blood pool tracers for preclinical magnetic particle imaging,” Nanoscale, vol. 9, no. 3, pp. 1299–1306, 2017. View at Publisher · View at Google Scholar
  128. B. Zheng, M. P. von See, E. Yu et al., “Quantitative magnetic particle imaging monitors the transplantation, biodistribution, and clearance of stem cells in vivo,” Theranostics, vol. 6, no. 3, pp. 291–301, 2016. View at Publisher · View at Google Scholar · View at Scopus
  129. B. Zheng, T. Vazin, P. W. Goodwill et al., “Magnetic particle imaging tracks the long-term fate of in vivo neural cell implants with high image contrast,” Scientific Reports, vol. 5, p. 14055, 2015. View at Publisher · View at Google Scholar · View at Scopus
  130. Z. Cai, N. Chattopadhyay, K. Yang et al., “111In-labeled trastuzumab-modified gold nanoparticles are cytotoxic in vitro to HER2-positive breast cancer cells and arrest tumor growth in vivo in athymic mice after intratumoral injection,” Nuclear Medicine and Biology, vol. 43, no. 12, pp. 818–826, 2016. View at Publisher · View at Google Scholar · View at Scopus
  131. B. Nowak, C. Weber, A. Schober et al., “Indium-111 oxine labelling affects the cellular integrity of haematopoietic progenitor cells,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 34, no. 5, pp. 715–721, 2007. View at Publisher · View at Google Scholar · View at Scopus
  132. Y. Wang, C. Xu, and H. Ow, “Commercial nanoparticles for stem cell labeling and tracking,” Theranostics, vol. 3, no. 8, pp. 544–560, 2013. View at Publisher · View at Google Scholar · View at Scopus
  133. J. Ding, Z. Zhao, C. Wang et al., “Bioluminescence imaging of transplanted human endothelial colony-forming cells in an ischemic mouse model,” Brain Research, vol. 1642, pp. 209–218, 2016. View at Publisher · View at Google Scholar · View at Scopus
  134. C. Vandeputte, V. Reumers, S. A. Aelvoet et al., “Bioluminescence imaging of stroke-induced endogenous neural stem cell response,” Neurobiology of Disease, vol. 69, pp. 144–155, 2014. View at Google Scholar
  135. P. J. Chen, Y. D. Kang, C. H. Lin et al., “Multitheragnostic multi-GNRs crystal-seeded magnetic nanoseaurchin for enhanced in vivo mesenchymal-stem-cell homing, multimodal imaging, and stroke therapy,” Advanced Materials, vol. 27, no. 41, pp. 6488–6495, 2015. View at Publisher · View at Google Scholar · View at Scopus
  136. D. Granot and E. M. Shapiro, “Accumulation of micron sized iron oxide particles in endothelin-1 induced focal cortical ischemia in rats is independent of cell migration,” Magnetic Resonance in Medicine, vol. 71, no. 4, pp. 1568–1574, 2014. View at Publisher · View at Google Scholar · View at Scopus
  137. K. Li, M. Yamamoto, S. J. Chan et al., “Organic nanoparticles with aggregation-induced emission for tracking bone marrow stromal cells in the rat ischemic stroke model,” Chemical Communications (Camb), vol. 50, no. 96, pp. 15136–15139, 2014. View at Publisher · View at Google Scholar · View at Scopus
  138. E. S. Lee, J. Chan, B. Shuter et al., “Microgel iron oxide nanoparticles for tracking human fetal mesenchymal stem cells through magnetic resonance imaging,” Stem Cells, vol. 27, no. 8, pp. 1921–1931, 2009. View at Publisher · View at Google Scholar · View at Scopus
  139. W. C. Shyu, C. P. Chen, S. Z. Lin, Y. J. Lee, and H. Li, “Efficient tracking of non-iron-labeled mesenchymal stem cells with serial MRI in chronic stroke rats,” Stroke, vol. 38, no. 2, pp. 367–374, 2007. View at Publisher · View at Google Scholar · View at Scopus
  140. K. S. Jang, K. S. Lee, S. H. Yang, and S. S. Jeun, “In vivo tracking of transplanted bone marrow-derived mesenchymal stem cells in a murine model of stroke by bioluminescence imaging,” Journal of Korean Neurosurgical Association, vol. 48, no. 5, pp. 391–398, 2010. View at Publisher · View at Google Scholar · View at Scopus